Clinical trial
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell
NCT00156858 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell
- Lead sponsor
- Alberta Health services
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 1998
- Completion date
- December 31, 2010
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic malignancy